Serum levels of ICAM‐1, VCAM‐1 and adiponectin were significantly higher in PBC patients than in NAFLD patients and CTRL; FGF19 was lower in PBC and NAFLD women than in CTRL (Figure 1, Table S1). This evidence concerns the gene ICAM1 and metabolic dysfunction-associated steatotic liver disease.